Parkwood LLC Astrazeneca PLC Transaction History

Parkwood LLC

$880 Million
Q4 2024

A detailed history of Parkwood LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Parkwood LLC holds 118,199 shares of AZN stock, worth $9.21 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares

118,199

Previous 72,685 62.62%

Holding current value

$9.21 Million

Previous $5.66 Million 36.75%

% of portfolio

0.88%

Previous 0.4%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$63.2 - $79.58 $2.88 Million - $3.62 Million	45,514 Added 62.62%	118,199 $7.74 Million
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $1.12 Million - $1.28 Million	14,645 Added 25.23%	72,685 $5.66 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $1.63 Million - $1.98 Million	-24,467 Reduced 29.65%	58,040 $4.53 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $6.03 Million - $6.87 Million	-98,729 Reduced 54.48%	82,507 $5.59 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $633,506 - $709,150	-10,236 Reduced 5.35%	181,236 $12.2 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $1.23 Million - $1.36 Million	18,983 Added 11.01%	191,472 $13 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $236,016 - $255,934	-3,376 Reduced 1.92%	172,489 $12.3 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $2.04 Million - $2.31 Million	32,326 Added 22.52%	175,865 $12.2 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $218,628 - $284,084	-4,033 Reduced 2.73%	143,539 $9.73 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $362,921 - $929,208	6,845 Added 4.86%	147,572 $8.09 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $2.44 Million - $2.92 Million	-41,101 Reduced 22.6%	140,727 $141,000
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $186,494 - $224,650	3,347 Added 1.88%	181,828 $12.1 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $5.62 Million - $6.64 Million	-104,010 Reduced 36.82%	178,481 $10.4 Million
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $2.73 Million - $2.98 Million	-49,078 Reduced 14.8%	282,491 $17 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $3.05 Million - $3.79 Million	62,916 Added 23.42%	331,569 $19.9 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $1.07 Million - $1.23 Million	22,669 Added 9.22%	268,653 $13.4 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $10.4 Million - $12.4 Million	214,154 Added 672.81%	245,984 $12.3 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $9.39 Million - $10.8 Million	-176,863 Reduced 84.75%	31,830 $9.36 Million
Q2 2020 Aug 11, 2020	SELL	$43.1 - $55.31 $2.12 Million - $2.72 Million	-49,114 Reduced 19.05%	208,693 $11 Million
Q1 2020 May 12, 2020	SELL	$37.79 - $51.33 $496,447 - $674,322	-13,137 Reduced 4.85%	257,807 $11.5 Million
Q4 2019 Feb 10, 2020	SELL	$42.46 - $50.46 $1.81 Million - $2.15 Million	-42,706 Reduced 13.62%	270,944 $13.5 Million
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $6.87 Million - $7.79 Million	171,321 Added 120.37%	313,650 $14 Million
Q2 2019 Aug 08, 2019	SELL	$37.28 - $41.68 $99,574 - $111,327	-2,671 Reduced 1.84%	142,329 $5.88 Million
Q1 2019 May 06, 2019	BUY	$35.49 - $43.02 $5.15 Million - $6.24 Million	145,000 New	145,000 $5.86 Million

Others Institutions Holding AZN

# of Institutions

1,365

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $242B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkwood LLC with notifications on news.

Account